| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director | Common Stock | 75,390 | $256,326 | $3.40 | 13 Jun 2025 | Direct |
| Aerovate Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 12,500 | $204,625 | $16.37 | 05 Jun 2024 | Direct |
| Verve Therapeutics, Inc. | Chief Financial Officer | Restricted Stock Units | 0 | $140,063 | $4.15 | 25 Jul 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Financial Officer | Common Stock | 0 | $0 | $11.23 | 25 Jul 2025 | Direct |
| Verve Therapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 0 | 25 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | 25 Jul 2025 | 7 | $0 | 4 | Chief Financial Officer | 28 Jul 2025, 17:15 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 13 Jun 2025 | 1 | -$39,474 | 4 | Director | 17 Jun 2025, 19:43 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 20:14 |
| VERV | Verve Therapeutics, Inc. | 01 Apr 2025 | 3 | -$13,902 | 4 | Chief Financial Officer | 03 Apr 2025, 17:00 |
| VERV | Verve Therapeutics, Inc. | 08 Jan 2025 | 3 | $0 | 4 | Chief Financial Officer | 10 Jan 2025, 09:00 |
| VERV | Verve Therapeutics, Inc. | 29 Nov 2024 | 3 | -$3,130 | 4 | Chief Financial Officer | 03 Dec 2024, 16:30 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 18 Jun 2024 | 1 | $0 | 4 | Director | 21 Jun 2024, 21:17 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 13 Jun 2024 | 1 | -$37,096 | 4 | Director | 17 Jun 2024, 19:18 |
| AVTE | Aerovate Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 18:00 |
| VERV | Verve Therapeutics, Inc. | 14 Feb 2024 | 2 | $0 | 4 | Chief Financial Officer | 16 Feb 2024, 16:30 |
| VERV | Verve Therapeutics, Inc. | 29 Nov 2023 | 3 | -$6,343 | 4 | Chief Financial Officer | 01 Dec 2023, 16:30 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 13 Jun 2023 | 2 | -$34,500 | 4 | Director | 15 Jun 2023, 21:01 |
| AVTE | Aerovate Therapeutics, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 18:00 |
| VERV | Verve Therapeutics, Inc. | 14 Feb 2023 | 1 | $0 | 4 | Chief Financial Officer | 16 Feb 2023, 16:00 |
| VERV | Verve Therapeutics, Inc. | 29 Nov 2022 | 3 | -$12,243 | 4 | Chief Financial Officer | 01 Dec 2022, 16:00 |
| AVTE | Aerovate Therapeutics, Inc. | 21 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 17:01 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 14 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:16 |
| VERV | Verve Therapeutics, Inc. | 11 Feb 2022 | 1 | $0 | 4 | Chief Financial Officer | 15 Feb 2022, 08:00 |
| VERV | Verve Therapeutics, Inc. | 29 Nov 2021 | 2 | $0 | 4 | Chief Financial Officer | 30 Nov 2021, 15:26 |
| VERV | Verve Therapeutics, Inc. | 29 Nov 2021 | 0 | $0 | 3 | Chief Financial Officer | 30 Nov 2021, 15:25 |
| AVTE | Aerovate Therapeutics, Inc. | 15 Jul 2021 | 1 | $0 | 4 | Director | 19 Jul 2021, 16:28 |
| AVTE | Aerovate Therapeutics, Inc. | 15 Jul 2021 | 0 | $0 | 3 | Director | 19 Jul 2021, 16:27 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 15 Jul 2021 | 1 | $0 | 4 | Director | 16 Jul 2021, 16:46 |
| PBYI | PUMA BIOTECHNOLOGY, INC. | 15 Jul 2021 | 0 | $0 | 3 | Director | 16 Jul 2021, 16:41 |